Cancer Treatment Research in Maryland
Cancer Treatment Research (93.395) awarded $162 million to recipients in Maryland in 112 grants from fiscal 2021 to 2025, 2.9% of the program's national total. The Johns Hopkins University received the most, $110 million.
- Awarded in Maryland$162 million
- Awards112
- Share of the program2.9%
- Rank among states11th of 50
- National total$5.6 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 53 | $27.8 million |
| FY 2022 | 53 | $29.9 million |
| FY 2023 | 45 | $29.1 million |
| FY 2024 | 57 | $32.9 million |
| FY 2025 | 61 | $42.6 million |
Recipients in Maryland
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| The Johns Hopkins University | Colleges and universities | 62 | $110 million |
| University of Maryland, Baltimore | Colleges and universities | 16 | $15.1 million |
| University of Maryland, College Park | Colleges and universities | 3 | $5.6 million |
| Isoprene Pharmaceuticals, Inc. | Small businesses | 2 | $3.0 million |
| Sonoval LLC | Small businesses | 2 | $2.8 million |
| Mirecule, Inc. | Small businesses | 2 | $2.8 million |
| Up Therapeutics LLC | Small businesses | 3 | $2.8 million |
| Rise Therapeutics LLC | Small businesses | 1 | $2.4 million |
| Oncosting, LLC | Small businesses | 1 | $2.2 million |
| ONCOC4 Inc | Small businesses | 1 | $1.9 million |
Open opportunities under this program
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)
- National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
- Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
- NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
- Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)
- Successor-in-Interest (Type 6 Parent Clinical Trial Optional)
- NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)
- Bioengineering Partnerships with Industry (U01 Clinical Trial Optional)
See all 47 on the program page
Questions people ask
How much Cancer Treatment Research money goes to Maryland?
$162 million from fiscal 2021 to 2025, across 112 awards. Maryland ranks 11th of 50 states and territories for this program.
Who receives Cancer Treatment Research money in Maryland?
The largest recipient is The Johns Hopkins University, with $110 million in 62 awards. Next are University of Maryland, Baltimore and University of Maryland, College Park.
Can organizations in Maryland apply now?
Yes, 47 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Cancer Treatment Research in other states
Other large programs in Maryland
- Grants to States for Medicaid
- Greenhouse Gas Reduction Fund: National Clean Investment Fund
- Education Stabilization Fund
- Highway Planning and Construction
- USAID Foreign Assistance for Programs Overseas
- 1332 State Innovation Waivers
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- National School Lunch Program
- Children's Health Insurance Program
- Title I Grants to Local Educational Agencies